Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
The human cornea has recently been described as a source of corneal stroma-derived mesenchymal stem cells (hMSCs). In vitro expansion of these cells involves basal medium supplemented with fetal bovine serum (FBS). As animal-derived serum can confer a risk of disease transmission and can be subject to considerable lot-to-lot variability, it does not comply with newer Good Manufacturing Practice (GMP)-required animal component-free culture protocols for clinical translation.
Pubmed ID: 28524929 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets HLA-DR
View all literature mentionsThis monoclonal targets CD90 (Thy-1)
View all literature mentionsThis monoclonal targets CD79a
View all literature mentionsThis polyclonal targets Human PPP5C
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD29
View all literature mentionsThis monoclonal targets CD13
View all literature mentionsThis monoclonal targets CD11b (Mac-1)
View all literature mentionsThis monoclonal targets CD105
View all literature mentions